Tag Archives: Veritas

Veritas Pharma

Veritas Announces Private Placement

Veritas Announces Private Placement

Veritas Pharma Inc. (the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), is pleased to announce that a non-brokered private placement offering of up to 9,090,910 units (“Units”) at a price of $0.22 per Unit for aggregate gross proceeds of up to $2,000,000 (the “Offering”).

Veritas Pharma

Veritas Pharma Enters into Agreement to Secure ACMPR License and Cannabis Growing Facility

VANCOUVER, British Columbia, Nov. 21, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), (“Veritas” or the “Company”), an emerging-stage pharmaceutical and IP development company, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Sechelt Organic Marijuana Inc.

Veritas Pharma

Veritas Pharma Embarks on Important Next Phase of Cannabis Research

VANCOUVER, Aug. 3, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is pleased to announce that through Cannevert Therapeutics Ltd, Veritas’ research arm, has developed several candidate cannabis strains and is now fully engaged in chemical and biological assessment of these key strains.

Veritas Pharma

Veritas Lists and Increases Private Placement on Bay Street Cannabis Web Portal

VANCOUVER, British Columbia, March 30, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:2VP) announces that the Company’s previously announced private placement has been listed on the newly created online investment platform, Bay Street Cannabis.


Top